Literature DB >> 21484163

Dietary chalcones with chemopreventive and chemotherapeutic potential.

Barbora Orlikova1, Deniz Tasdemir, Frantisek Golais, Mario Dicato, Marc Diederich.   

Abstract

Chalcones are absorbed in the daily diet and appear to be promising cancer chemopreventive agents. Chalcones represent an important group of the polyphenolic family, which includes a large number of naturally occurring molecules. This family possesses an interesting spectrum of biological activities, including antioxidative, antibacterial, anti-inflammatory, anticancer, cytotoxic, and immunosuppressive potential. Compounds of this family have been shown to interfere with each step of carcinogenesis, including initiation, promotion and progression. Moreover, numerous compounds from the family of dietary chalcones appear to show activity against cancer cells, suggesting that these molecules or their derivatives may be considered as potential anticancer drugs. This review will focus primarily on prominent members of the chalcone family with an 1,3-diphenyl-2-propenon core structure. Specifically, the inhibitory effects of these compounds on the different steps of carcinogenesis that reveal interesting chemopreventive and chemotherapeutic potential will be discussed.

Entities:  

Year:  2011        PMID: 21484163      PMCID: PMC3092904          DOI: 10.1007/s12263-011-0210-5

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  194 in total

1.  Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism.

Authors:  Julia Strathmann; Karin Klimo; Sven W Sauer; Jürgen G Okun; Jochen H M Prehn; Clarissa Gerhäuser
Journal:  FASEB J       Date:  2010-03-24       Impact factor: 5.191

2.  Dihydrochalcones from the leaves of Pieris japonica.

Authors:  Guang-Min Yao; Yu Ding; Jian-Ping Zuo; Hong-Bing Wang; Yu-Bo Wang; Bing-Yang Ding; Pauline Chiu; Guo-Wei Qin
Journal:  J Nat Prod       Date:  2005-03       Impact factor: 4.050

3.  Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.

Authors:  Ahcène Boumendjel; Julien Boccard; Pierre-Alain Carrupt; Edwige Nicolle; Madeleine Blanc; Annabelle Geze; Luc Choisnard; Denis Wouessidjewe; Eva-Laure Matera; Charles Dumontet
Journal:  J Med Chem       Date:  2008-02-23       Impact factor: 7.446

4.  p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes.

Authors:  J L Dean; M Brook; A R Clark; J Saklatvala
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

5.  Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells.

Authors:  Yu-Feng Kuo; Ying-Zhen Su; Yen-Hsueh Tseng; Sheng-Yang Wang; Hsi-Ming Wang; Pin Ju Chueh
Journal:  Free Radic Biol Med       Date:  2010-04-14       Impact factor: 7.376

6.  Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells.

Authors:  Ya-Ling Hsu; Po-Lin Kuo; Chun-Ching Lin
Journal:  Life Sci       Date:  2005-02-12       Impact factor: 5.037

7.  Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.

Authors:  Babasaheb P Bandgar; Shrikant S Gawande
Journal:  Bioorg Med Chem       Date:  2010-01-11       Impact factor: 3.641

8.  YL-I-108, a synthetic chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 murine macrophages: involvement of heme oxygenase-1 induction and blockade of activator protein-1.

Authors:  Pil-Hoon Park; Hak Sung Kim; Jin Hur; Xing Yu Jin; Ying Lan Jin; Dong Hwan Sohn
Journal:  Arch Pharm Res       Date:  2009-01-29       Impact factor: 4.946

9.  Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages.

Authors:  Ji-Yeon Kim; Seung Jae Park; Kyung-Jin Yun; Young-Wuk Cho; Hee-Juhn Park; Kyung-Tae Lee
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

10.  [Effects of hydroxy safflor yellow A on blood vessel and mRNA expression with VEGF and bFGF of transplantation tumor with gastric adenocarcinoma cell line BGC-823 in nude mice].

Authors:  Shengyan Xi; Qian Zhang; Hua Xie; Lintao Liu; Chaoyang Liu; Xuemin Gao; Jianjun Zhang; Likun Wu; Lili Qian; Xiaoying Deng
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2009-03
View more
  40 in total

1.  Antioxidant and anti-acetylcholinesterase activities of extracts and secondary metabolites from Acacia cyanophylla.

Authors:  Lotfi Ghribia; Hatem Ghouilaa; Amel Omrib; Malek Besbesb; Hichem Ben Janneta
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  An overview on cardamonin.

Authors:  Luís Moreira Gonçalves; Inês Maria Valente; José António Rodrigues
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

3.  6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Authors:  Shengnan Du; Jeffrey G Sarver; Christopher J Trabbic; Paul W Erhardt; Allen Schroering; William A Maltese
Journal:  Cancer Chemother Pharmacol       Date:  2018-11-13       Impact factor: 3.333

Review 4.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

Review 5.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

6.  Regiospecificity of human UDP-glucuronosyltransferase isoforms in chalcone and flavanone glucuronidation determined by metal complexation and tandem mass spectrometry.

Authors:  Emily D Niemeyer; Jennifer S Brodbelt
Journal:  J Nat Prod       Date:  2013-05-29       Impact factor: 4.050

7.  Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells.

Authors:  David Drutovic; Martina Chripkova; Martina Pilatova; Peter Kruzliak; Pal Perjesi; Marek Sarissky; Monica Lupi; Giovanna Damia; Massimo Broggini; Jan Mojzis
Journal:  Tumour Biol       Date:  2014-07-10

8.  Cyclic chalcone analogue KRP6 as a potent modulator of cell proliferation: an in vitro study in HUVECs.

Authors:  Lenka Ivanova; Lenka Varinska; Martina Pilatova; Peter Gal; Peter Solar; Pal Perjesi; Karel Smetana; Alexander Ostro; Jan Mojzis
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

9.  Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer.

Authors:  Catherine C Going; Dhanir Tailor; Vineet Kumar; Alisha M Birk; Mallesh Pandrala; Meghan A Rice; Tanya Stoyanova; Sanjay Malhotra; Sharon J Pitteri
Journal:  J Proteome Res       Date:  2018-09-20       Impact factor: 4.466

10.  4-Hydroxyhalcone effects on cisplatin-induced genotoxicity model.

Authors:  Aref Nazari; Mina Mirian; Mahmoud Aghaei; Mehdi Aliomrani
Journal:  Toxicol Res (Camb)       Date:  2021-01-05       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.